DE60131331D1 - Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung - Google Patents

Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung

Info

Publication number
DE60131331D1
DE60131331D1 DE60131331T DE60131331T DE60131331D1 DE 60131331 D1 DE60131331 D1 DE 60131331D1 DE 60131331 T DE60131331 T DE 60131331T DE 60131331 T DE60131331 T DE 60131331T DE 60131331 D1 DE60131331 D1 DE 60131331D1
Authority
DE
Germany
Prior art keywords
fluoxetine
medicaments
preparation
dispersible tablets
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60131331T
Other languages
English (en)
Inventor
Sesma Angel Ursua
De Narvajas Alcalde F Martinez
Congosto Carlos Yanez-Sedeno
Oroz Juan Pedro Larumbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Cinfa SA
Original Assignee
Laboratorios Cinfa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Cinfa SA filed Critical Laboratorios Cinfa SA
Application granted granted Critical
Publication of DE60131331D1 publication Critical patent/DE60131331D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60131331T 2000-08-01 2001-07-27 Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung Expired - Lifetime DE60131331D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200001952A ES2185452B2 (es) 2000-08-01 2000-08-01 Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.

Publications (1)

Publication Number Publication Date
DE60131331D1 true DE60131331D1 (de) 2007-12-27

Family

ID=8494546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131331T Expired - Lifetime DE60131331D1 (de) 2000-08-01 2001-07-27 Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung

Country Status (3)

Country Link
EP (1) EP1177788B1 (de)
DE (1) DE60131331D1 (de)
ES (1) ES2185452B2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
WO2007098809A1 (en) * 2006-03-03 2007-09-07 Symrise Gmbh & Co. Kg Pressed agglomerates suitable for consumption having retarded aroma release
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法
CN112741819B (zh) * 2020-12-11 2022-07-22 山西仟源医药集团股份有限公司 一种盐酸氟西汀胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
US4816298A (en) * 1987-11-27 1989-03-28 The Dow Chemical Company Method of making a granular, cold water dispersible coating composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
DE4141268A1 (de) * 1991-12-14 1993-06-17 Merck Patent Gmbh Pharmazeutische zubereitung
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
US6096341A (en) * 1998-10-30 2000-08-01 Pharma Pass Llc Delayed release tablet of bupropion hydrochloride

Also Published As

Publication number Publication date
ES2185452A1 (es) 2003-04-16
EP1177788B1 (de) 2007-11-14
EP1177788A2 (de) 2002-02-06
ES2185452B2 (es) 2004-03-16
EP1177788A3 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
DE60131331D1 (de) Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung
DE60100186D1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
ATE259805T1 (de) Als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
DE60009791D1 (de) Feste pharmazeutische Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung
DE60124291D1 (de) Extrusions-blasgeformter zusammendrückbarer behälter und verfahren zu dessen herstellung
DE60321450D1 (de) Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
DE60037857D1 (de) Saugfähiger Gegenstand und Verfahren zu dessen Herstellung
IS5526A (is) 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum
DE60039438D1 (de) Elektrostatischer ultraschallwandler und verfahren zu dessen herstellung
DE60006777D1 (de) Undurchlässiger Schlauch und Verfahren zu dessen Herstellung
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
DE69934463D1 (de) Cellulosischer Verbundwerkstoff und Verfahren zu dessen Herstellung
DE60017830D1 (de) Ladeluftkühler und Verfahren zu dessen Herstellung
DE60034975D1 (de) Ionisationsstab und Verfahren zu dessen Herstellung
DE60221950D1 (de) Kieselsäure sowie Verfahren zu ihrer Herstellung
DE60111195D1 (de) Wässerige formulierungen und verfahren zu ihrer herstellung
DE60318167D1 (de) Arzneiform und Verfahren zu ihrer Herstellung
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE294175T1 (de) 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
ATE354356T1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
DE60203178D1 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
ATE264837T1 (de) N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
DE69808793T2 (de) Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung
DE50109137D1 (de) Speicherkondensator und zugehörige Kontaktierungsstruktur sowie Verfahren zu deren Herstellung
DE60022890D1 (de) Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
8332 No legal effect for de